Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Vascular Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cooke, J. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooke, J. P
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The endothelium: a new target for therapy

John P Cooke

Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA

At one time considered merely a monolayer of cells lining the vascular conduit, the endothelium has emerged recently as an organ with functions as complex as any in the body. A highly active regulatory organ, the endothelium senses and assesses the hemodynamic, humoral, and inflammatory signals to which it is constantly exposed by the blood and responds by secreting factors that affect vessel tone and structure. These interactions are not merely of academic interest. It has been increasingly recognized that endothelial dysfunction plays a pivotal role in the development and progression of atherosclerosis and coronary artery disease.

Key Words: atherosclerosis • l-arginine • nitric oxide • vasodilation

Vascular Medicine, Vol. 5, No. 1, 49-53 (2000)
DOI: 10.1177/1358836X0000500108


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum
n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects
Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Sydow, C. E. Mondon, J. Schrader, H. Konishi, and J. P. Cooke
Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity
Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 692 - 697.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Nicholls, Z. Wang, R. Koeth, B. Levison, B. DelFraino, V. Dzavik, O. W. Griffith, D. Hathaway, J. A. Panza, S. E. Nissen, et al.
Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction
Circulation, November 13, 2007; 116(20): 2315 - 2324.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Couillard, G. Ruel, W. R. Archer, S. Pomerleau, J. Bergeron, P. Couture, B. Lamarche, and N. Bergeron
Circulating Levels of Oxidative Stress Markers and Endothelial Adhesion Molecules in Men with Abdominal Obesity
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6454 - 6459.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
N. Nair, R. K Oka, L. D Waring, E. M Umoh, C B. Taylor, and J. P Cooke
Vascular compliance versus flow-mediated vasodilation: correlation with cardiovascular risk factors
Vascular Medicine, November 1, 2005; 10(4): 275 - 283.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. K. Chacko, R. T. Chandler, A. Mundhekar, N. Khoo, H. M. Pruitt, D. F. Kucik, D. A. Parks, C. G. Kevil, S. Barnes, and R. P. Patel
Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H908 - H915.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
K. Sydow, C. E Mondon, and J. P Cooke
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
Vascular Medicine, July 1, 2005; 10(1_suppl): S35 - S43.
[Abstract] [PDF]


Home page
Vasc MedHome page
K. Sydow, C. E Mondon, and J. P Cooke
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
Vascular Medicine, May 1, 2005; 10(2_suppl): S35 - S43.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. G. Melo, M. Gnecchi, A. S. Pachori, D. Kong, K. Wang, X. Liu, R. E. Pratt, and V. J. Dzau
Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular Disease
Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1761 - 1774.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. L. Gornik and M. A. Creager
Arginine and Endothelial and Vascular Health
J. Nutr., October 1, 2004; 134(10): 2880S - 2887S.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. B. Hu and M. J. Stampfer
Is Type 2 Diabetes Mellitus a Vascular Condition?
Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1715 - 1716.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. A Brown and F. B Hu
Dietary modulation of endothelial function: implications for cardiovascular disease
Am. J. Clinical Nutrition, April 1, 2001; 73(4): 673 - 686.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Coats, F. Johnston, J. MacDonald, J. J. V. McMurray, and C. Hillier
Endothelium-Derived Hyperpolarizing Factor : Identification and Mechanisms of Action in Human Subcutaneous Resistance Arteries
Circulation, March 27, 2001; 103(12): 1702 - 1708.
[Abstract] [Full Text] [PDF]